[Sinphar Pharmaceutical Co., Ltd.] Q1 2026 EPS 0.39 NTD

Sinphar Pharmaceutical reported its Q1 2026 earnings with operating revenue of 827 million NTD, net income of 68 million NTD, and an EPS of 0.39 NTD.
その他NQ 0/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: March 1, 2026 at 09:00
  • 🔍 Collected: May 16, 2026 at 08:00 (1823h 0m after Published)
  • 🤖 AI Analyzed: May 16, 2026 at 08:31 (31 min after Collected)
Company Code: 1734
Company Name: Sinphar Pharmaceutical Co., Ltd.
Industry: Biotechnology & Medical Care
Year/Quarter: Q1 2026
Basic EPS: 0.39 NTD
Operating Revenue: 0.827 billion NTD
Net Income: 0.068 billion NTD

Back to Newsroom (9)